AstraZeneca vaccine dose ready for use as soon as Canada approves US manufacturing site

Over 1.5 million doses of the Ottawa-Oxford-AstraZeneca vaccine are heading to the state now that Health Canada has approved the US site where they were manufactured.

How many Canadians get them as part of a fallout from Monday’s decision to suspend the use of the AstraZeneca vaccine for people under the age of 55 until further analysis of the risk of blood clots is made. I still don’t know if I want to.

There were signs in British Columbia on Wednesday that many didn’t need persuasiveness.

A long lineup was formed outside the pharmacy, and it was first administered to people over the age of 55. This was after the state’s original plan for administration to key workers failed due to a suspension of administration to young Canadians.

This weekend, Ontario will expand AstraZeneca’s rollout, doubling the number of pharmacies that acquire it, and expanding its age from 60 to 64 to 55 to 64.

Most states say they have used up almost all of the first 500,000 episodes delivered last month, including 300,000 episodes that expire on Friday.

Mia Loveson